Fosun International Down 1%, Unit Henlius Biotech Up 5%, as Board Approves Incentive Plans

MT Newswires Live
2025/06/30

Fosun International (HKG:0656) said unit Shanghai Henlius Biotech's (HKG:2696) board approved the adoption of share option and restricted share unit (RSU) schemes, subject to shareholder approval,

Shares of conglomerate Fosun International closed 1% lower on Monday, while Henlius Biotech closed 5% higher.

Henlius Biotech is planning to make initial grants of 6,985,000 options and 6,985,000 RSUs to 279 participants under the schemes, which will be valid for 10 years.

The potential grantees of the scheme include employees, related entities, and service providers.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10